Covid-19 vaccine soon for emergency use in those aged 18 and above as the US pharma company seeks regulatory approval for its vaccine in India, sources told news agency PTI.
As per the sources, Mumbai-based Cipla has applied for import and marketing authorisation of Moderna's covid jabs. Cipla filed an application on Monday seeking permission for import of Moderna COVID-19 vaccine referring to DCGI notices dated April 15 and June 1 stating that if the vaccine is approved by the USFDA for EUA, the vaccine can be granted marketing authorization without bridging trial and assessment of safety data of first 100 beneficiaries of vaccines shall be submitted before rolling out in immunization programme.